VEGFA and angiosarcoma: Recurrent gains of a small region of chromosome 4q12 containing KIT and VEGFR2 genes have been reported in sporadic angiosarcomas [12], and overexpression of vascular endothelial growth factors and their receptors have been linked with the good response of these tumors to sunitinib [17].